U.S. stock futures slipped on Tuesday after authorities recommended suspending the Johnson & Johnson vaccine due to reported blood clotting concerns, the WSJ reported.
- S&P 500 futures slid 0.3% after holding steady in the European morning after the index hovered near its recent record closing high on Monday.
- Nasdaq 100 futures edged 0.1% lower.
- The 10-year Treasury note climbed 1.680% from 1.674% on Monday. It shot up as high as 1.749% at the end of March from 0.915% near the start of 2021.
- The pan-continental Stoxx Europe 600 gained 0.02%.
- Japan’s Nikkei 225 Index advanced 0.7%; Hong Kong’s Hang Seng index added 0.2%; while the Shanghai Composite Index fell 0.5% on weaker-than-expected March export data.
- Bitcoin climbed over 4% to trade above $62,500 apiece, according to CoinDesk. America’s biggest cryptocurrency exchange plans to go public on Wednesday.
- The Food and Drug Administration and the Centers for Disease Control and Prevention are reviewing data on six reported cases of blood clotting among individuals inoculated with the Johnson & Johnson vaccine.